- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Dr. Kathiresan Rajasekar has been appointed as President – International Business at Gufic Biosciences Limited, effective immediately. With over 28 years of experience in the pharmaceutical sector, he brings a wealth of knowledge, having managed P&L for businesses exceeding $125 million and driving consistent growth across various functions such as Sales, Marketing, and Business Development. Dr. Rajasekar has extensive expertise in establishing global injectable manufacturing facilities and specializes in Techno-Commercial operations in regulated markets. His experience includes leadership roles at Emcure Pharmaceuticals and IPCA Laboratories, underscoring a strong track record in navigating both domestic and global pharmaceutical landscapes. This appointment may enhance Gufic's strategic positioning in international markets, presenting growth opportunities for shareholders.